You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Bayer Healthcare Llc Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for BAYER HEALTHCARE LLC, and what generic and branded alternatives to BAYER HEALTHCARE LLC drugs are available?

BAYER HEALTHCARE LLC has twenty-five approved drugs.

Summary for Bayer Healthcare Llc

US Patents:	0
Tradenames:	20
Ingredients:	10
NDAs:	25
Patent Litigation for Bayer Healthcare Llc:	See patent lawsuits for Bayer Healthcare Llc

Drugs and US Patents for Bayer Healthcare Llc

+ Get email alerts for changes to this table

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Bayer Healthcare Llc	CLARITIN HIVES RELIEF	loratadine	SYRUP;ORAL	020641-003	Nov 19, 2003		DISCN	Yes	No		⤷ Subscribe				⤷ Subscribe
Bayer Healthcare Llc	CLARITIN	loratadine	SYRUP;ORAL	020641-002	Nov 27, 2002		OTC	Yes	Yes		⤷ Subscribe				⤷ Subscribe
Bayer Healthcare Llc	GYNE-LOTRIMIN COMBINATION PACK	clotrimazole	CREAM, TABLET;TOPICAL, VAGINAL	020289-002	Apr 26, 1993		DISCN	Yes	No		⤷ Subscribe				⤷ Subscribe
Bayer Healthcare Llc	CLARITIN-D	loratadine; pseudoephedrine sulfate	TABLET, EXTENDED RELEASE;ORAL	019670-002	Nov 27, 2002		OTC	Yes	Yes		⤷ Subscribe				⤷ Subscribe
Bayer Healthcare Llc	OCUCLEAR	oxymetazoline hydrochloride	SOLUTION/DROPS;OPHTHALMIC	018471-001	May 30, 1986		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Bayer Healthcare Llc	CLARITIN	loratadine	TABLET;ORAL	019658-002	Nov 27, 2002		OTC	Yes	Yes		⤷ Subscribe				⤷ Subscribe
Bayer Healthcare Llc	CHLOR-TRIMETON	chlorpheniramine maleate; pseudoephedrine sulfate	TABLET, EXTENDED RELEASE;ORAL	018397-001	Approved Prior to Jan 1, 1982		DISCN	Yes	No		⤷ Subscribe				⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for Bayer Healthcare Llc

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Bayer Healthcare Llc	CLARITIN-D	loratadine; pseudoephedrine sulfate	TABLET, EXTENDED RELEASE;ORAL	019670-002	Nov 27, 2002	4,863,931*PED	⤷ Subscribe
Bayer Healthcare Llc	CLARITIN	loratadine	TABLET;ORAL	019658-002	Nov 27, 2002	4,863,931*PED	⤷ Subscribe
Bayer Healthcare Llc	CLARITIN REDITABS	loratadine	TABLET, ORALLY DISINTEGRATING;ORAL	020704-002	Nov 27, 2002	4,659,716*PED	⤷ Subscribe
Bayer Healthcare Llc	SHADE UVAGUARD	avobenzone; octinoxate; oxybenzone	LOTION;TOPICAL	020045-001	Dec 7, 1992	4,522,807	⤷ Subscribe
Bayer Healthcare Llc	CLARITIN-D	loratadine; pseudoephedrine sulfate	TABLET, EXTENDED RELEASE;ORAL	019670-002	Nov 27, 2002	4,659,716*PED	⤷ Subscribe
Bayer Healthcare Llc	MYCELEX	clotrimazole	CREAM;TOPICAL	018183-001	Approved Prior to Jan 1, 1982	3,660,577	⤷ Subscribe
Bayer Healthcare Llc	CLARITIN REDITABS	loratadine	TABLET, ORALLY DISINTEGRATING;ORAL	020704-002	Nov 27, 2002	4,863,931*PED	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.